Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.
Beter M. et al, (2025), Sci rep, 15
The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.
Chang C-H. et al, (2024), Nat commun, 15
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Pagnamenta AT. et al, (2023), Genome med, 15
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
Feng Y. et al, (2023), Gastroenterology
HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta.
Dickson A. et al, (2023), Open biol, 13
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2
Davis-Gilbert ZW. et al, (2023), Acs medicinal chemistry letters
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma.
Feng Y. et al, (2023), Biorxiv
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood cancer j, 13
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood cancer j, 13
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
Sevinç K. et al, (2022), Stem cell reports, 17, 2629 - 2642
The Paradoxical Efficacy of KDM6 Inhibition in Germinal Centre B-Cell Lymphomas
Close K. et al, (2021), Blood, 138
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Heward JA. et al, (2021), Blood
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection.
Sandoval DR. et al, (2021), Biorxiv
Discovery of Prolyl-tRNA Synthetase As a Novel Target in Multiple Myeloma
Kurata K. et al, (2021), Blood, 138
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.
Foley AR. et al, (2020), Ann neurol, 88, 332 - 347
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
Heward JA. et al, (2020)
The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma.
Ozyerli-Goknar E. et al, (2019), Cell death dis, 10
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.
Fagan V. et al, (2019), J med chem, 62, 9008 - 9025